BIOMAT Database Logo BIOMAT Database Logo

Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. 1968

D A Roe

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008286 Malabsorption Syndromes General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients. Malabsorption Syndrome,Syndrome, Malabsorption,Syndromes, Malabsorption
D008297 Male Males
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002792 Cholestyramine Resin A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion. Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D004586 Electrophoresis An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current. Electrophoreses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic

Related Publications

D A Roe
Essential hyperlipemia with xanthomatosis.
September 1953, A.M.A. archives of dermatology and syphilology,
D A Roe
[Essential hyperlipemia, Xanthomatosis, diabetes].
January 1960, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
D A Roe
[Treatment of essential hyperlipemia with clofibrate].
June 1969, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
D A Roe
[Essential hyperlipemia and diabetic xanthomatosis].
August 1958, Arztliche Wochenschrift,
D A Roe
[Two cases of xanthomatosis; essential hyperlipemia and familial xanthomatosis; effects of local heparin].
April 1956, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
D A Roe
[LIPID METABOLISM IN ESSENTIAL HYPERLIPEMIA AND XANTHOMATOSIS].
January 1965, Voprosy pitaniia,
D A Roe
[Myeloma, hyperlipemia and xanthomatosis].
January 1965, Nouvelle revue francaise d'hematologie,
D A Roe
[IDIOPATHIC HYPERLIPEMIA WITH PAPULO-ERUPTIVE XANTHOMATOSIS].
June 1964, Srpski arhiv za celokupno lekarstvo,
D A Roe
Metabolic effects of clofibrate and of cholestyramine administration to dogs.
December 1971, Biochemical pharmacology,
D A Roe
[Xanthomatosis in idiopathic hyperlipemia and pancreatitis].
May 1956, Wiener klinische Wochenschrift,
Copied contents to your clipboard!